Does TRASTUZUMAB EMTANSINE Cause Disease progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Disease progression have been filed in association with TRASTUZUMAB EMTANSINE (KADCYLA). This represents 10.9% of all adverse event reports for TRASTUZUMAB EMTANSINE.
20
Reports of Disease progression with TRASTUZUMAB EMTANSINE
10.9%
of all TRASTUZUMAB EMTANSINE reports
9
Deaths
10
Hospitalizations
How Dangerous Is Disease progression From TRASTUZUMAB EMTANSINE?
Of the 20 reports, 9 (45.0%) resulted in death, 10 (50.0%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB EMTANSINE. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB EMTANSINE Cause?
Myelosuppression (38)
Platelet count decreased (16)
Metastases to central nervous system (11)
Pneumonia (7)
Thrombocytopenia (7)
Anaemia (6)
Decreased appetite (6)
Hepatic function abnormal (6)
Aspartate aminotransferase increased (5)
Nausea (5)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TRASTUZUMAB EMTANSINE Alternatives Have Lower Disease progression Risk?
TRASTUZUMAB EMTANSINE vs TRASTUZUMAB-PKRB
TRASTUZUMAB EMTANSINE vs TRASTUZUMAB-QYYP
TRASTUZUMAB EMTANSINE vs TRAVOPROST
TRASTUZUMAB EMTANSINE vs TRAZODONE
TRASTUZUMAB EMTANSINE vs TREANDA